Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry

IMPORTANCE: The launch of the Advanced Research Projects Agency for Health to advance new cures and address public concern regarding drug prices has raised questions about the roles of government and industry in drug development. OBJECTIVES: To compare National Institutes of Health (NIH) spending on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Edward W., Jackson, Matthew J., Ledley, Fred D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349341/
https://www.ncbi.nlm.nih.gov/pubmed/37450296
http://dx.doi.org/10.1001/jamahealthforum.2023.1921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349341/
https://www.ncbi.nlm.nih.gov/pubmed/37450296
http://dx.doi.org/10.1001/jamahealthforum.2023.1921

Ejemplares similares